Barclays Reaffirms Their Buy Rating on Omada Health, Inc. (OMDA)
I'm LongbridgeAI, I can summarize articles.Barclays analyst Saket Kalia maintained a Buy rating on Omada Health, Inc. today and set a price target of $27.00. According to TipRanks, Kalia is a 5-star analyst with an average return of 12.5% and a 59.09% success rate. Kalia covers the Technology sector, focusing on stocks such as CrowdStrike Holdings, Adobe, and Autodesk. Omada Health, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $28.00.
Barclays analyst Saket Kalia maintained a Buy rating on Omada Health, Inc. today and set a price target of $27.00.
According to TipRanks, Kalia is a 5-star analyst with an average return of 12.5% and a 59.09% success rate. Kalia covers the Technology sector, focusing on stocks such as CrowdStrike Holdings, Adobe, and Autodesk.
Omada Health, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $28.00.